These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29071284)

  • 1. Characterizing Cefepime Neurotoxicity: A Systematic Review.
    Appa AA; Jain R; Rakita RM; Hakimian S; Pottinger PS
    Open Forum Infect Dis; 2017; 4(4):ofx170. PubMed ID: 29071284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefepime-induced neurotoxicity: a systematic review.
    Payne LE; Gagnon DJ; Riker RR; Seder DB; Glisic EK; Morris JG; Fraser GL
    Crit Care; 2017 Nov; 21(1):276. PubMed ID: 29137682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy.
    Fugate JE; Kalimullah EA; Hocker SE; Clark SL; Wijdicks EF; Rabinstein AA
    Crit Care; 2013 Nov; 17(6):R264. PubMed ID: 24200036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephalosporin-related neurotoxicity: Metabolic encephalopathy or non-convulsive status epilepticus?
    Triplett JD; Lawn ND; Chan J; Dunne JW
    J Clin Neurosci; 2019 Sep; 67():163-166. PubMed ID: 31201049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonconvulsive status epilepticus cases arising in connection with cephalosporins.
    Bora I; Demir AB; Uzun P
    Epilepsy Behav Case Rep; 2016; 6():23-7. PubMed ID: 27408805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure.
    Martínez-Rodríguez JE; Barriga FJ; Santamaria J; Iranzo A; Pareja JA; Revilla M; dela Rosa CR
    Am J Med; 2001 Aug; 111(2):115-9. PubMed ID: 11498064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible coma secondary to cefepime neurotoxicity.
    Abanades S; Nolla J; Rodríguez-Campello A; Pedro C; Valls A; Farré M
    Ann Pharmacother; 2004 Apr; 38(4):606-8. PubMed ID: 14982986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Onset Non-Convulsive Status Epilepticus Despite Cefepime Renal Dose Adjustment.
    Oyenuga M; Oyenuga A; Rauf A; Balogun O; Singh N
    Cureus; 2021 Jan; 13(1):e12689. PubMed ID: 33614301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefepime-Induced Neurotoxicity Presenting with Nonconvulsive Status Epilepticus Admitted as a Stroke Alert.
    Cunningham JM; Sachs KV; Allyn R
    Am J Case Rep; 2020 Mar; 21():e921643. PubMed ID: 32147665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefepime-induced neurotoxicity: systematic review.
    Maan G; Keitoku K; Kimura N; Sawada H; Pham A; Yeo J; Hagiya H; Nishimura Y
    J Antimicrob Chemother; 2022 Oct; 77(11):2908-2921. PubMed ID: 35971666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefepime-Induced Nonconvulsive Status Epilepticus in a Pediatric Patient with Normal Renal Function.
    Nguyen C; Clegg T; Kumar A; Paudel S
    Child Neurol Open; 2022; 9():2329048X221119575. PubMed ID: 35968536
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged Cefepime-Induced Neurotoxicity in a Patient with End-Stage Renal Disease.
    Nguyen DD; Lai S
    Am J Case Rep; 2022 Jan; 23():e934083. PubMed ID: 35067669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective review of neurotoxicity induced by cefepime and ceftazidime.
    Chow KM; Szeto CC; Hui AC; Wong TY; Li PK
    Pharmacotherapy; 2003 Mar; 23(3):369-73. PubMed ID: 12627936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Looking beyond the Obvious: Cefepime-induced Nonconvulsive Status Epilepticus.
    Anuhya V; Kunder SK; Madhyastha S; Nayak V; Acharya RV; Ramamoorthi K; Arivazhahan A; Gangula RS
    J Pharmacol Pharmacother; 2017; 8(3):145-147. PubMed ID: 29081627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review.
    Lam S; Gomolin IH
    Pharmacotherapy; 2006 Aug; 26(8):1169-74. PubMed ID: 16863493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-convulsive status epilepticus secondary to adjusted cefepime doses in patients with chronic renal failure].
    Saurina A; Vera M; Pou M; López Pedret J; Darnell A; Campistol JM; Cases A
    Nefrologia; 2000; 20(6):554-8. PubMed ID: 11217651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefepime neurotoxicity despite renal adjusted dosing.
    Gangireddy VG; Mitchell LC; Coleman T
    Scand J Infect Dis; 2011 Oct; 43(10):827-9. PubMed ID: 21604923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of Cefepime encephalopathy, being difficult to distinguish from non-convulsive status epilepticus during the treatment of bacterial meningitis].
    Toda Y; Yamazaki M; Ota T; Fujisawa Y; Kimura K
    Rinsho Shinkeigaku; 2016 Oct; 56(10):678-683. PubMed ID: 27680224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefepime-induced nonconvulsive status epilepticus: case report and review.
    Thabet F; Al Maghrabi M; Al Barraq A; Tabarki B
    Neurocrit Care; 2009; 10(3):347-51. PubMed ID: 19034700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cefepime-induced encephalopathy: clinical and electroencephalographic features in seven patients].
    Bragatti JA; Rossato R; Ziomkowski S; Kliemann FA
    Arq Neuropsiquiatr; 2005 Mar; 63(1):87-92. PubMed ID: 15830071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.